Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bumetanide in Autism Medication and Biomarker Study
NL-OMON44696Phase 2Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Autism Spectrum Disorder (ASD) comparing Bumetanide with Placebo (2 arms). Started Jun 2016; status: active, not recruiting.
02
Drugs
bumetanide
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NL-OMON44696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44696.